Drugs / rMenB+OMV-NZ
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01148524 | Aug 2010 → Jan 2012 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rMenB+OMV-NZ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01148524 ↗ |
| Modality | Vaccine | “vaccination course” NCT01148524 ↗ |